Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers

Ludek Slavik, Jana Prochazkova, Martin Prochazka, Ondrej Simetka, Antonin Hlusi, Jana Ulehlova

. 2011 ; 155 (4) : 333-337.

Language English Country Czech Republic

Document type Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc12007343

Grant support
NS10319 MZ0 CEP Register

Aim. The aim of this study was to assess coagulation markers of endothelial damage and examine new markers of endothelial activation such as matrix metalloproteinases (MMPs) in a group of healthy pregnant women. Matrix metalloproteinase (MMP)-2, in particular, plays a major role in the degradation of the extracellular matrix confirming its essential function in both the survival (angiogenesis) and death of endothelial cells. Detection of specific coagulation factors, mainly released from the vascular endothelium such as vWF, sTM (soluble thrombomodulin) and ePCR (endothelial protein C receptor) and factors dependent on endothelial activation such as t-PA and PAI-1, could provide information on possible endothelial dysfunction and help differentiate pregnant patients with an altered thrombotic state. Methods. Healthy pregnant women underwent complete assessment for endothelial damage (as vWF, vWF activity, sTM, ePCR, EMP, MMP-2, MMP-9 and TIMP-2) using the ELISA and other methods. Results and Conclusions. The results show that endothelial activation during pregnancy is different from that in other pathological conditions involving endothelial damage and typically characterized by higher levels of both coagulation endothelial markers and MMPs. In pregnancy, changes in extracellular matrix composition and matrix metalloproteinase activity also occur and promote vascular remodeling but, only in the uterus. Predisposing risk factors for epithelial dysfunction, and vascular mediators associated with vascular remodeling must be assessed from concentrations in whole blood. The levels of MMPs are not increased in the circulation and the local situation in the uterus cannot be monitored this way. However, MMP-2 processes and modulates the functions of many other vasoactive and pro-inflammatory molecules including adrenomedullin, big endothelin-1, calcitonin gene-related peptide, CCL7/MCP-3, CXCL12/SDF-1, galectin-3, IGFBP-3, IL-1 Beta, S100A8, and S100A9. These molecules represent new potential molecular markers of endothelial damage during pregnancy.

References provided by Crossref.org

Obsahuje 1 tabulku

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc12007343
003      
CZ-PrNML
005      
20140910110901.0
007      
ta
008      
120309s2011 xr f 000 0eng||
009      
AR
024    7_
$a 10.5507/bp.2011.031 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Slavík, Luděk $7 xx0081908 $u Department of Hemato-oncology, University Hospital Olomouc
245    14
$a The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers / $c Ludek Slavik, Jana Prochazkova, Martin Prochazka, Ondrej Simetka, Antonin Hlusi, Jana Ulehlova
500    __
$a Obsahuje 1 tabulku
504    __
$a Literatura $b 47
520    9_
$a Aim. The aim of this study was to assess coagulation markers of endothelial damage and examine new markers of endothelial activation such as matrix metalloproteinases (MMPs) in a group of healthy pregnant women. Matrix metalloproteinase (MMP)-2, in particular, plays a major role in the degradation of the extracellular matrix confirming its essential function in both the survival (angiogenesis) and death of endothelial cells. Detection of specific coagulation factors, mainly released from the vascular endothelium such as vWF, sTM (soluble thrombomodulin) and ePCR (endothelial protein C receptor) and factors dependent on endothelial activation such as t-PA and PAI-1, could provide information on possible endothelial dysfunction and help differentiate pregnant patients with an altered thrombotic state. Methods. Healthy pregnant women underwent complete assessment for endothelial damage (as vWF, vWF activity, sTM, ePCR, EMP, MMP-2, MMP-9 and TIMP-2) using the ELISA and other methods. Results and Conclusions. The results show that endothelial activation during pregnancy is different from that in other pathological conditions involving endothelial damage and typically characterized by higher levels of both coagulation endothelial markers and MMPs. In pregnancy, changes in extracellular matrix composition and matrix metalloproteinase activity also occur and promote vascular remodeling but, only in the uterus. Predisposing risk factors for epithelial dysfunction, and vascular mediators associated with vascular remodeling must be assessed from concentrations in whole blood. The levels of MMPs are not increased in the circulation and the local situation in the uterus cannot be monitored this way. However, MMP-2 processes and modulates the functions of many other vasoactive and pro-inflammatory molecules including adrenomedullin, big endothelin-1, calcitonin gene-related peptide, CCL7/MCP-3, CXCL12/SDF-1, galectin-3, IGFBP-3, IL-1 Beta, S100A8, and S100A9. These molecules represent new potential molecular markers of endothelial damage during pregnancy.
650    _2
$a biologické markery $x analýza $7 D015415
650    _2
$a koagulační faktory $x metabolismus $7 D001779
650    _2
$a cévní endotel $x fyziologie $x patofyziologie $7 D004730
650    _2
$a extracelulární matrix $x metabolismus $7 D005109
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a matrixové metaloproteinasy $x metabolismus $7 D020782
650    _2
$a těhotenství $x fyziologie $7 D011247
650    _2
$a komplikace těhotenství $x patofyziologie $7 D011248
650    _2
$a tkáňové inhibitory metaloproteinas $x metabolismus $7 D019714
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Procházková, Jana $7 xx0067433 $u Department of Hemato-oncology, University Hospital Olomouc
700    1_
$a Procházka, Martin, $7 xx0019288 $u Department of Obsterics and Gynecology, University Hospital Olomouc $d 1970-
700    1_
$a Šimetka, Ondřej, $7 xx0096494 $u Department of Obsterics and Gynecology, University Hospital Ostrava $d 1970-
700    1_
$a Hluší, Antonín $7 xx0074065 $u Department of Hemato-oncology, University Hospital Olomouc
700    1_
$a Úlehlová, Jana $7 xx0117725 $u Department of Hemato-oncology, University Hospital Olomouc
773    0_
$t Biomedical papers $x 1213-8118 $g Roč. 155, č. 4 (2011), s. 333-337 $w MED00012606
910    __
$a ABA008 $b A 1502 $c 958 $y 2 $z 0
990    __
$a 20120309115236 $b ABA008
991    __
$a 20140910111303 $b ABA008
999    __
$a ok $b bmc $g 900475 $s 764207
BAS    __
$a 3
BMC    __
$a 2011 $b 155 $c 4 $d 333-337 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
GRA    __
$a NS10319 $p MZ0
LZP    __
$a 2012-11/dkme
Back

Find record

Citation metrics

Archiving options